Early Patient Withdrawal
Early patient withdrawal/dropout/discontinuation is when a participant leaves a clinical study before all the required protocol-required elements of the clinical study are completed.
Early patient withdrawal/dropout/discontinuation is when a participant leaves a clinical study before all the required protocol-required elements of the clinical study are completed.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
